Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan and Clofarabine Conditioning for Allo-SCT in Advanced Leukemia/Lymphoma
NCT00990249Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2009
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2009; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT00990249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00990249.